Annex E

Table of Contents

• E.1 Introduction
• E.2 Equine Information Document
• E.3 Equine Written Description Terms
• E.4 List of Veterinary Dugs Not Permitted For Use in Equine Slaughtered For Food With Canadian Brand Name Examples (January 18, 2010)
• E.5 List of "Essential" Veterinary Drugs Permitted in Equine With a 6 Month Withdrawal Period With Canadian Brand Name Examples
• E.6 List of Veterinary Drugs Safe For Use in Equine Intended For Food Production For Which Withdrawal Periods Have Been Determined With Canadian Brand Name Examples (Under development)
• E.7 Frequently Asked Questions and Answers

---

E.1 Introduction

Effective July 31, 2010, it will be mandatory for all Canadian Food Inspection Agency (CFIA) inspected facilities in Canada engaged in the slaughter of equine for edible purposes to have complete records for all animals (domestic and imported) presented for slaughter. These records will include unique identification for each animal, a record of illness and a record of medical treatments administered to the animal for the six-month period preceding slaughter. The template entitled "Equine Information Document" (EID) of this annex (see E.2) shall be used by equine owners for this purpose.

A completed EID contains a standardized description of the animal or unique lot identification, as well as a comprehensive record of the equine's medical treatment for at least the preceding six months. The various options for identification, including visual and written descriptions, are listed in the document. The document is intended to accompany the equine, at the time of ownership transfer, to the buyer of the animal. The EID requires a signed declaration by the owner of the equine as to the accuracy of the information recorded in the EID.

E.2 Equine Information Document

EQUINE INFORMATION DOCUMENT

This document represents and provides for the minimum requirements of written and pictorial identification as well as a record of medical history and declaration for equine (horses, donkeys, zebras and their crosses) presented for slaughter in Canada. Alternatives to filling out the written description and picture identification below are given at the end of Part 1.

Part 1 Identification

Written Identification

Name of the animal (write N/A if the animal has no name)
Primary location of the animal
(Land location or legal address or Premise Identification Number)
Primary use(s) of the animal. Circle one or more of the following: recreation/companion animal/ pleasure riding, breeding, ranch/farm work, public work, private industry work, performance/sport/show, racing, rodeo, urine production, food production, if other please specify
Sex - Mare/Filly, Gelding, Stud/Colt (Circle one) month and year of birth . (if known)
Country of Birth (if known) Height in hands (1 hand = 4 inches)
Refer to Section E.3 for terms to be used for the following equine colour and marking identification section
Body Color
Markings: Head
Body
Limbs: Right Front Right Hind
Left Front Left Hind

The following seven items must be completed or marked N/A if not applicable
Pedigree registry and registration number
Microchip number and location
Passport ID number
Unique Equine Life Number
Or other unique identifier
In the case of an Equine Information Document completed by the previous owner; name of previous owner:
List visible acquired marks (brands, tattoos, scars, etc.) and location
/

Picture Identification

Attach, by stapling to this document, a single page containing the name (if applicable) of the equine and clear printed colour pictures of the animal showing each of the views in the diagram below. The pictures should be large enough to see the detail required. The views shall be printed on a standard 8.5 X 11" page. Ensure that at least 90% of the picture contains the side or portion of the animal shown in the part of the diagram below to be depicted. Take close ups of any visible acquired marks such as brands and attach. Owners, please ensure that the written description and pictures attached agree and then sign and date the picture page.

Diagram

Click on image for larger view

Alternatives to Written and Picture Identification

The picture and written description identification in the above sections will not be required to be fully completed if the identification information listed above is contained in either of the following four alternative options. Any information required above but not contained in the options below must be completed in the applicable section above.

1. The written description information and as a substitute for pictures, the silhouette above, is completed by a licensed Veterinarian or an authorized person*. Lines are to be drawn on the diagrams above representing white areas on the animal where applicable. Mark whorls with an "X". Mark the location of scars with an arrow ->. Draw in acquired marks e.g. brands.

   Name and signature of Veterinarian/authorized person
   License/authorization number
   * Authorized persons would include those authorized by an Animal Pedigree Act recognized pedigree registry, or recognized by Equine Canada to issue identification passports or brand inspectors employed provincially.

2. For pedigree registered animals that have official registration papers with picture and written description identification, a legible colour copy of the registration papers may be attached to this document.
3. For non pedigree registered equines with an official passport, the passport may be attached.
4. When a complete Equine Information Document (EID) (including part 1) has been provided by a previous owner(s), provided that the EID from the previous owner(s) is attached to this document.

Part 2 History

I, (name of owner) of ////-- (state your full contact address, (street number or post office box number/city/province or state/ postal code or zip code, phone number) am the owner** of the animal identified on this document and have had uninterrupted possession, care or control of the animal identified below from (indicate date care or control started) to (indicate end date).

1. Have any drugs or vaccines been administered to or consumed by the animal during the shorter of the following 3 periods: since January 31, 2010, in the last 180 days, or during the time you owned the animal? Circle Yes or No. If yes, write the name the drug(s) or vaccine(s), last date of use, withdrawal period(s) *** and for drugs, the amount used (dose) per treatment if the label does not indicate a dose or if drug is used at a dosage different than the label indicates
   
   
   
   
   (use back of page if more space is needed).
2. Has the animal identified on this document to your knowledge been diagnosed with an illness during the shorter of the following 3 periods: since January 31, 2010, in the last 180 days, or during the time you owned the animal? Circle Yes or No. If yes, provide details with dates of diagnosis and recovery
   
   
   
   
3. Has the animal identified on this document to your knowledge been treated with a substance listed under the table named substances not permitted for use in food producing equine found in section E.4 during the shorter of the following 3 periods: since January 31, 2010, in the last 180 days, or during the time you owned the animal, Circle Yes or No.

Notes

** An owner is a person who owns or has the possession, care or control of an animal.
*** For information on withdrawal periods for drugs safe for use in food producing animals but without a withdrawal period for equine listed on the label, please consult sections E.5 and E.6 or contact your veterinarian. Indicate the withdrawal period (number of days/hours before the animal can be slaughtered) for vaccines found on the label.

Part 3 Declaration

OWNER DECLARATION

As the owner of the animal identified on this document I hereby certify that the information stated in this Equine Information Document is accurate and complete.

I understand that, effective July 31, 2010, at least six continuous months of documented acceptable history is required for an equine presented for processing in an establishment inspected by the Canadian Food Inspection Agency. As such, I have the option of attaching to this document, completed Equine Information Document(s) from previous owner(s) in order to cover the required six continuous months of documented history.

(Signature of owner)

// (Date DD/MM/YY)

E.3 Equine Written Description Terms

The Equine Information Document (EID) requires an accurate standardized written description and visual identification that may include a completed equine outline instead of picture identification. The following terms shall be used to complete the written description portion of the EID. In addition to brands or tattoos that the horse may bear, look for and identify unique distinguishing marks such as scars. A copy of descriptive nomenclature for colouring and markings as well as instructions for filling out the equine diagram have been produced by the International Equestrian Federation has been adapted for use, and is included on the following pages.

Height

The height of a horse is normally recorded in "hands", measured at the top of the withers. One "hand" equals four inches.

Colour

Black: Black pigment is general throughout the coat, limbs, mane and tail, with no pattern factor present other than white markings.

Brown: There is a mixture of black and brown pigment in the coat, with black limbs, mane and tail.

Bay-brown: The predominate colour is brown, with muzzle bay, black limbs, mane and tail.

Bay: Bay varies considerably in shade from dull red approaching brown, to a yellowish colour approaching chestnut, but it can be distinguished from the chestnut by the fact that the bay has a black mane and tail and almost invariably has black on the limbs and tips of the ears.

Chestnut: A Chestnut may be any shade of red with no black points like the bay. Think of the different colors of a penny from brand new to very old and tarnished; chestnuts can come in all these colours. Also chestnuts may be described as follows if applicable:

• Liver Chestnut is very dark red like a very old tarnished penny.
• Dark Chestnut is mahogany red.
• Light Chestnut is light red to yellow.
• Sorrel is yellowish to reddish to a brownish shade body coat. The mane and tail are usually the same or darker than the body.
• Chestnut or sorrel with a flaxen mane and tail is a chestnut/sorrel colour body coat with a light coloured to almost white mane and tail.

Grey: The body coat is a varying mosaic of black and white hair, with black skin. With advancing age, the coat grows lighter in colour. The flea-bitten grey may contain three colours or the two basic colours and should be so described. A pure white is exceptional.

Roan: Mixture of white hairs with one or two other hair colours in the coat. May be described as Red Roan (white and chestnut hair), Blue Roan (white and black hair) as applicable.

Strawberry: The coat is chestnut with a mixture of white hairs.

Piebald: The body coat consists of large irregular patches of black and white. The line of demarcation between the two colours is generally well defined.

Skewbald: The body consists of large irregular patches of white and of any definite colour except black. The line of demarcation between the colours is generally well-defined.

Dun: The body coat is cream colour with black mane and tail.

Cream: The body coat is of a cream colour, with nonpigmented skin. The iris is deficient in pigment and is often devoid of it, giving the eye a pinkish or bluish appearance.

Palomino: The body coat is a newly-minted gold coin colour (lighter or darker shades are permissible) with a white mane and tail.

Appaloosa: Body colour is grey, covered with a mosaic of black or brown spots.

Unique Coat Marking Additional Identifying Terms

Grey-ticked: White hairs are sparsely distributed through the coat or any specified part of the body.

Flecked: Small collections of white hairs occur distributed irregularly in any part of the body. May be further qualified as Lightly Flecked or Heavily Flecked depending on the amount of white hair.

Black Marks or Dark Marks: Small areas of black or dark hairs occur together with the basic (usually lighter colored) body colour hairs.

Spots: Small, more or less circular, collections of hairs differring from the general body colour occur, distributed in various parts of the body. The position and colour of the spots must be stated.

Leopard: The term Leopard may be added when the horse has many more or less circular collections of hairs of differring from the general body colour.

Patch: This term should be used to describe any larger well-defined irregular area (not covered by previous definitions) of hairs differring from the general body colour. The colour, shape, position and extent shall be described.

Zebra Marks: Dark or black striping on the limbs, neck or quarters. The affected part of the animal must be stated.

Withers Stripe: Zebra band across the withers.

List: A dorsal band of black hair which extends from the withers backwards to the base of the tail.

White Marks

The characteristics of all white marks must be described.

A white mark can be regular or irregular. It can be mixed with the hair of the coat, completely or in part, or at the edge. It can be bordered, a band of black skin shows under the white hair at the edge of the mark (the area appears bluish).

Head

The description should begin at the forehead, followed by the nasal bone, the muzzle, lips and chin.

Star: Any white mark on the forehead. Size, shape, intensity, position and coloured markings (if any) on the white to be specified. Should the markings in the region of the centre of the forehead consist of a few white hairs only, it shall be so described and not referred to as a star.

Stripe: The narrow white marking down the face not wider than the flat anterior surface of the nasal bones. In many cases, the star and stripe are continuous and should be described as star and stripe connected. When the stripe is separate and distinct from the star it shall be described as interrupted stripe. When no star is present the point of origin of the stripe shall be indicated. The termination of the stripe and any variation in breadth, direction and any markings on the white shall be so stated, e.g. broad stripe, narrow stripe, inclined to left, etc. Any markings in the white area shall be stated.

Blaze: A white marking covering almost the whole of the forehead between the eyes and extending beyond the width of the nasal bones and usually to the muzzle. Any variations in direction, termination and any markings on the white shall be stated.

White Face: When the white covers the forehead and front of the face, extending laterally towards the mouth. The extension may be unilateral or bilateral, in which case it shall be described accordingly.

Snip: An isolated white marking, independent of those already named, and situated between or in the region of the nostrils. Its size, position and intensity shall be specified. When a snip is connected with a stripe it shall be recorded as such, e.g. star, stripe connected snip.

Flesh Mark: Lack of pigmentation. A flesh mark is described as such and not as a white mark. Black spots within the flesh mark are to be indicated. All lip markings, whether flesh marks or white marks, shall be accurately described.

White Muzzle: When the white embraces both lips and extends to the region of the nostrils.

Limbs

All white markings on the limbs must be accurately defined and the upper limit precisely stated with reference to points of the anatomy, e.g. white to mid-pastern, white to upper third of cannon. The use of such terms as "sock" or "stocking" are not acceptable. The exact location must be specified, examples are listed below:

Examples:

• White coronet, white pastern, white fetlock, white to knee, white to hock, white to hind quarter;
• White patch on coronet (anterior, lateral, medial, posterior);
• White ring around limb: does not extend down to the coronet.

The presence of coloured spots in white marks shall be recorded. Black spots in a white coronet are referred to as Ermine marks.

Hoofs: Any variation in the hoof pigment shall be noted.

Whorls - Cowlicks

Whorls or cowlicks are changes in the hair pattern, and may take various forms simple, tufted, feathered or sinuous. Their position must be clearly specified with an "X" at their location on the horse.

Illustrations of White Markings

Equine Face Markings

Equine Legs Markings

The Diagram

The diagram may be filled in by a qualified individual as defined on the Equine Information Document in lieu of picture identification.

General

• The diagram must be filled in using both a red ballpoint pen and a black ballpoint pen.
• Blue ink must never be used because it is difficult to photocopy.
• Inks which run must be avoided (e.g. felt pens, ink pans).
• Coloured pencils which can be erased must not be used.
• The ballpoint pen used must have a broad point.

Procedure

• The narrative should be completed first using a black ballpoint pen, followed by the diagram indicating all the distinctive marks.
• Ensure that the diagram and the narrative agree.

A careful check must be made to ensure that all reference to left and right agree and no ambiguity exists.

Red Ballpoint Pen

Everything which appears in white on the horse must be shown in red on the diagram.

1. White Marks

   White marks must be clearly outlined, with irregularities indicated, without shading but lightly hatched-in if desired.

2. Bordered Marks

   A white bordered mark has a definite outline, which is bluish and corresponds to the black skin under the white hairs. Bordered markings are indicated by a double line.

3. Mixed Marks

   Mixed hairs are indicated by cross-hatching.

4. Few White Hairs

   Few white hairs or grey-ticked areas are indicated by single short lines.

5. Unpigmented Areas

   Unpigmented areas such as flesh marks, wall-eyes, or stripes on the hoofs are entirely coloured in red.

6. White Patches

   Large white patches on piebald or skewbald horses should be cross hatched-in or line-shaded to differentiate them from other patches.

7. Various
   • The presence of white hairs in the mane and tail should be indicated with red lines.
   • Permanent white marks in the coat acquired through trauma, freeze branding, surgery, etc. should be indicated in the diagram as for other white marks and by an arrow painting at their location.

Black-ballpoint Pen

Identifying markings which are not white on the horse must be shown in black on the diagram.

1. Whorls

   Whorls are indicated by an "x", if the whorl is elongated, it is shown by a continuous line from the "x". The exact location of the whorls is very important.

2. Black Spots and Marks

   Black spots or marks on the coat or within a white mark or flesh mark must be outlined in black and left unshaded.

3. Scars

   Scars due to surgery, treatment or accidents are indicated by arrows pointing at their location.

4. Brand Marks

   Brand marks should be drawn in black; if the shape is not visible the brand is to be considered as a scar and indicated by an arrow.

5. Zebra Marks, Wither Stripes and Lists

   Zebra Marks, wither stripes and lists are indicated by thick black lines following the mark(s).

E.4 List of Veterinary Drugs Not Permitted For Use in Equine Slaughtered for Food with Canadian Brand Name Examples (January 18, 2010)

Non Permitted Drug Name	Examples of Brand or Common Names	Species Indicated on the Label
Aristolochia species and preparations thereof	Not Approved for Veterinary Use in Canada	Not Applicable (N/A)
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Olaquindox Not Approved for Veterinary Use in Canada	N/A
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Carbadox Not currently marketed in Canada (stop sale order in effect)	N/A
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Tylosin Growth promotion use restriction only Tylosin 10 Premix Tylosin 40 Premix Tylan 10 Tylan 40 Tylan 100 Tylan 50 Sulfa-G	Swine, Beef, Chicken, Turkey
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Bacitracin BMD 110G	Chicken, Turkey, Swine
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Zinc Bacitracin Powder 110	Chicken, Swine
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Albac Powder 11%	Chicken, Swine
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Albac 110P Zinc Bacitracin Premix	Chicken, Swine
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Baciferm-PB-50	Chicken, Swine
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Oribiotic Ointment	Dog
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Albac 110	Chicken, Turkey, Swine
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	BNPH Ointment	Dog, Cat
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	BNP Ointment	Dog, Cat
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Bambermycins (Flavomycin) Flavomycin 4 (bambermycins)	Chicken, Turkey
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Virginiamycin Stafac 22	Chicken, Swine
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Stafac 44	Chicken, Swine
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Stafac 500	Chicken, Swine
Antibiotics used for growth promotion purposes such as olaquindox, carbadox, and tylosin	Virginiamycin 44 Premix	Chicken, Swine
Arsanilic acid	Pro-Gen 20%	Chicken, Turkey
Arsanilic acid	Pro-Gen 100%	Chicken, Turkey
Arsanilic acid	3-Nitro-20	Chicken, Turkey, Swine
Arsanilic acid	Histostat 50	Turkey
Beta-agonists used for growth promotion purposes, including clenbuterol and ractopamine	Clenbuterol Banned by regulations1 for sale in food producing animals.	N/A
Beta-agonists used for growth promotion purposes, including clenbuterol and ractopamine	Ventipulmin Solution	Horses not intended for food
Beta-agonists used for growth promotion purposes, including clenbuterol and ractopamine	Ventipulmin Syrup	Horses not intended for food
Beta-agonists used for growth promotion purposes, including clenbuterol and ractopamine	Ractopamine Optaflexx 100 Premix	Cattle
Beta-agonists used for growth promotion purposes, including clenbuterol and ractopamine	Paylean 20	Swine
Beta-agonists used for growth promotion purposes, including clenbuterol and ractopamine	Zilpaterol hydrochloride Zilmax Medicated Premix	Cattle
Boldenone	Equipoise Injectable	Horses not intended for food
Colchicine	Not Approved for Veterinary Use in Canada	N/A
Chloramphenicol	Banned by regulations1 for sale in food producing animals. Chlor-500 Chlor-1000 Chloramphenicol 1% Ointment ChlorPalm 250	Dog, Cat
Chloroform	Approved as a veterinary drug in Canada, however currently not manufactured	N/A
Chlorpromazine	Not Approved for Veterinary Use in Canada	N/A
Dapsone	Not Approved for Veterinary Use in Canada	N/A
Methandriol	Not Approved for Veterinary Use in Canada	N/A
Nitrofurans including Furazolidone, Furaltadone, nitrofurantoin, nitrofurazone	Banned by regulations1 for sale in food producing animals. Furazolidone Not Approved for Veterinary Use in Canada Furox Aerosol Powder, Topazone Aerosol Powder, Furall registered for veterinary use in the USA.	N/A
Nitrofurans including Furazolidone, Furaltadone, nitrofurantoin, nitrofurazone	Furaltadone Not Approved for Veterinary Use in Canada	N/A
Nitrofurans including Furazolidone, Furaltadone, nitrofurantoin, nitrofurazone	Nitrofurantoin Equifur	Horses not intended for food, Dog, Cat
Nitrofurans including Furazolidone, Furaltadone, nitrofurantoin, nitrofurazone	Nitrofurazone Niderm Ointment	Horses not intended for food
Nitrofurans including Furazolidone, Furaltadone, nitrofurantoin, nitrofurazone	Nitrofurazone Ointment	General use
Nitrofurans including Furazolidone, Furaltadone, nitrofurantoin, nitrofurazone	Nitrofur Solution	Horses not intended for food
Nitrofurans including Furazolidone, Furaltadone, nitrofurantoin, nitrofurazone	Nitro Ointment	Horses not intended for food
Nitrofurans including Furazolidone, Furaltadone, nitrofurantoin, nitrofurazone	Pinkaway Powder	Dog, Cat
5-Nitroimidazoles including dimetridazole, metronidazole, and ronidazole	Banned by regulations1 for sale in food producing animals. Not Approved for Veterinary Use in Canada	N/A
Oestradiol	Estradiol Cypionate in Oil	Horses not intended for food, Cattle, Dog, Cat
Oestradiol	Estrus	Cattle
Oestradiol	Uni-Bol	Horses not intended for food
Oestradiol	Component E-C Component E-C Implants with Tylan Component E-H Component E-H Implants with Tylan Component E-S Component E-S Implants with Tylan Component TE-H Component TE-H Implants with Tylan Component TE-S Component TE-S Implants with Tylan Compudose Implants Revalor-200 Revalor-G Revalor-H Revalor-S Revalor-XS Synovex C Synovex S Synovex H Synovex Choice Synovex Plus	Note that these are implants that carry only a cattle indication
Phenylbutazone	Butazone 400 Butazone 1000 Butazone Concentrate Butequine Buzone Concentrate Phenylbutazone Phenylbutazone Injection Phenylbutazone Powder Phenylbutazone Tablets Phenylbutazone Tabs	Note that all of the products listed carry an indication for use in equine (but not equine intended to be slaughtered for food)
Resorcylic acid lactones including zeranol	Zeranol Ralgro	Beef Note that this product carries only a cattle indication
Stanozolol	Not Approved for Veterinary Use in Canada, however Winstrol is registered for veterinary use in the USA.	N/A
Steroidal hormones used for growth promotion purposes (estradiol or melengestrol acetate singly, or the combinations of estradiol and progesterone; estradiol and testosterone; estradiol and trenbolone acetate etc.)	Component E-C Component E-C Implants with Tylan Component E-H Component E-H Implants with Tylan Component E-S Component E-S Implants with Tylan Component TE-H Component TE-H Implants with Tylan Component TE-S Component TE-S Implants with Tylan Compudose Implants MGA 100 Premix Revalor-200 Revalor-G Revalor-H Revalor-S Revalor-XS Synovex C Synovex S Synovex H Synovex Choice Synovex Plus	Note that these products carry only a cattle indication
Stilbenes, stilbene derivatives, and their salts and esters including diethylstilbestrol	Banned by regulations1 for sale in food producing animals. Diethylstilbestrol Stilbestrol	Dog, Cat
Stilbenes, stilbene derivatives, and their salts and esters including diethylstilbestrol	Stilbestrol Tablets	Dog, Cat
Thyrostats, antithyroid agents administered under any circumstances for the purpose of growth promotion	Approved for use in humans. Use in animals would be under veterinary control, but animals treated with these substances would not be eligible for slaughter.	N/A

¹ As per Section C.01.610.1 of the Food and Drug Regulations:

No person shall sell a drug for administration to animals that produce food or that are intended for consumption as food if that drug contains

(a) chloramphenicol or its salts or derivatives;
(b) a 5-nitrofuran compound;
(c) clenbuterol or its salts or derivatives;
(d) a 5-nitroimidazole compound; or
(e) diethylstilbestrol or other stilbene compounds

As per Section B.01.048 of the Food and Drug Regulations

(1) No person shall sell

(a) any animal intended for consumption as food if any product containing any drug listed in subsection (2) has been administered to the animal;
(b) any meat, meat by-products, eggs or milk intended for consumption as food and derived from an animal if any product containing any drug listed in subsection (2) has been administered to that animal; or
(c) any meat, meat by-products, eggs or milk that contains any residue of any drug listed in subsection (2).

(2) The drugs referred to in subsection (1) are

(a) chloramphenicol and its salts and derivatives;
(b) a 5-nitrofuran compound;
(c) clenbuterol and its salts and derivatives;
(d) a 5-nitroimidazole compound; and
(e) diethylstilbestrol and other stilbene compounds.

E.5 List of "Essential" Veterinary Drugs Permitted in Equine With a 6 Month Withdrawal Period With Canadian Brand Name Examples

Drug Use	Drug	Canadian Brand Name Examples
Sedation and Premedication (and antagonism)	Acepromazine	Ace Acevet 10 Tablets Acevet 25 Tablets Acevet Injection Atravet 10 mg Injectable Atravet Soluble Granules
Sedation and Premedication (and antagonism)	Atipamezole	Antisedan
Sedation and Premedication (and antagonism)	Diazepam	No known manufacture for veterinary use in Canada
Sedation and Premedication (and antagonism)	Midazolam	No known manufacture for veterinary use in Canada
Sedation and Premedication (and antagonism)	Naloxone	No known manufacture for veterinary use in Canada
Sedation and Premedication (and antagonism)	Propofol	PropoFlo Rapinovet
Sedation and Premedication (and antagonism)	Sarmazenil	No known manufacture for veterinary use in Canada
Sedation and Premedication (and antagonism)	Tiletamine	No known manufacture for veterinary use in Canada
Sedation and Premedication (and antagonism)	Zolazepam	No known manufacture for veterinary use in Canada
Hypotension or Respiratory Stimulation During Anaesthesia	Dobutamine	No known manufacture for veterinary use in Canada
Hypotension or Respiratory Stimulation during Anaesthesia	Dopamine	No known manufacture for veterinary use in Canada
Hypotension or Respiratory Stimulation during Anaesthesia	Ephedrine	Antihistamine Antihistamine Powder Antihist Solution Pyrahist-10
Hypotension or Respiratory Stimulation during Anaesthesia	Glycopyrrolate	No known manufacture for veterinary use in Canada
Hypotension or Respiratory Stimulation during Anaesthesia	Noradrenaline	No known manufacture for veterinary use in Canada
Analgesia	Buprenorphine	No known manufacture for veterinary use in Canada
Analgesia	Fentanyl	No known manufacture for veterinary use in Canada
Analgesia	Morphine	No known manufacture for veterinary use in Canada
Analgesia	Pethidine	No known manufacture for veterinary use in Canada
Muscle Relaxants and Associated Substances	Atracurium	No known manufacture for veterinary use in Canada
Muscle Relaxants and Associated Substances	Edrophonium	No known manufacture for veterinary use in Canada
Muscle Relaxants and Associated Substances	Guaifenesin	No known manufacture for veterinary use in Canada for the use indicated
Inhalation Anaesthetics	Servoflurane	No known manufacture for veterinary use in Canada
Local Anaesthetics	Bupivacaine	No known manufacture for veterinary use in Canada
Local Anaesthetics	Oxybuprocaine	No known manufacture for veterinary use in Canada
Local Anaesthetics	Prilocaine	No known manufacture for veterinary use in Canada
Cardiovascular	Digoxin	No known manufacture for veterinary use in Canada
Cardiovascular	Quinidine Sulfate and Quinidine Gluconate	No known manufacture for veterinary use in Canada
Cardiovascular	Procainamide	No known manufacture for veterinary use in Canada
Cardiovascular	Propanolol	No known manufacture for veterinary use in Canada
Convulsions	Phenytoin	No known manufacture for veterinary use in Canada
Convulsions	Primidone	No known manufacture for veterinary use in Canada
Gastrointestinal	Bethanechol	No known manufacture for veterinary use in Canada
Gastrointestinal	Dioctyl Sodium Sulfosuccinate	No known manufacture for veterinary use in Canada
Gastrointestinal	Metoclopramide	No known manufacture for veterinary use in Canada
Gastrointestinal	Propantheline bromide	No known manufacture for veterinary use in Canada
Rhabdomyolysis	Dantrolene sodium	No known manufacture for veterinary use in Canada
Antimicrobials	Ticarcillin	No known manufacture for veterinary use in Canada
Antimicrobials	Azithromycin	No known manufacture for veterinary use in Canada
Antimicrobials	Rifampicin	No known manufacture for veterinary use in Canada
Antimicrobials	Amikacin	Amiglyde
Respiratory	Ambroxol	No known manufacture for veterinary use in Canada
Respiratory	Ipratropium bromide	No known manufacture for veterinary use in Canada
Respiratory	Oxymetazolin	No known manufacture for veterinary use in Canada
Antiprotozoal	Isometamidium	No known manufacture for veterinary use in Canada
Antiprotozoal	Pyrimethamine	Quinnoxine-S Sulfaquinoxaline-S
Ophthalmic	Acyclovir	No known manufacture for veterinary use in Canada
Ophthalmic	Idoxuridine	No known manufacture for veterinary use in Canada
Ophthalmic	Phenylephrine	No known manufacture for veterinary use in Canada
Ophthalmic	Tropicamide	No known manufacture for veterinary use in Canada
Ophthalmic	Dorzolamide	No known manufacture for veterinary use in Canada
Ophthalmic	Latanoprost	No known manufacture for veterinary use in Canada
Ophthalmic	Timolol maleate	No known manufacture for veterinary use in Canada
Ophthalmic	Cyclosporin A	Optimmune
Ophthalmic	Ketorolac	No known manufacture for veterinary use in Canada
Ophthalmic	Ofloxacin	No known manufacture for veterinary use in Canada
Ophthalmic	Fluoresceine	No known manufacture for veterinary use in Canada
Ophthalmic	Rose Bengal	No known manufacture for veterinary use in Canada
Ophthalmic	Hydroxypropyl methylcellulose	No known manufacture for veterinary use in Canada
Hyperlipaemia	Insulin	Caninsulin
Fungal Infection	Griseofulvin	No known manufacture for veterinary use in Canada
Fungal Infection	Ketoconazole	No known manufacture for veterinary use in Canada
Fungal Infection	Miconazole	Conofite Cream 2% Dermazole Shampoo Surolan Drops
Fungal Infection	Nystatin	Canaural Ear Drops Panalog Cream Panalog Ointment
Miscellaneous	Chondroitin Sulfate	Chotin
Miscellaneous	Domperidone	No known manufacture for veterinary use in Canada
Miscellaneous	Hydroxyethylstarch	No known manufacture for veterinary use in Canada
Miscellaneous	Imipramine	No known manufacture for veterinary use in Canada
Miscellaneous	Thyrotropin releasing hormone	No known manufacture for veterinary use in Canada
Miscellaneous	Barium sulphate	No known manufacture for veterinary use in Canada
Miscellaneous	Iohexol	No known manufacture for veterinary use in Canada
Miscellaneous	Iopamidol	No known manufacture for veterinary use in Canada

E.6 List of Veterinary Drugs Safe For Use in Equine Intended For Food Production For Which Withdrawal Periods Have Been Determined With Canadian Brand Name Examples (Under development)

E.7 Frequently Asked Questions and Answers

Q1 Why should I fill out an EID?

A1 All equines which may be used for food must be presented with a completed and acceptable Equine Information Document (EID) at the time of slaughter starting July 31, 2010. In the event that the animal becomes unwanted, if the owner wants to keep the salvage value and salvage options with respect to human consumption of their animal as high as possible, they will need to accurately fill out an EID for animals they wish to sell.

Q2 Will all equine owners need to fill out an EID?

A2 It is not mandatory that all equine owners fill out Equine Information Documents for equines they own. The requirement applies to equines which may be used for food.

Q3 Why do we have to keep track of medication used starting January 31, 2010?

A3 Slaughter facilities handling equines in Canada will need at least a six month history of medication use for equine brought to the facility starting July 31, 2010.

Q4 When do I need to fill out the EID?

A4 The EID can be filled out any time before the sale of your equine, but it is important to keep track of medications used and illness occurrence during the time you own the animal, either on the EID itself or another record used to fill out the EID before you sell your animal.

Q5 How do I include pictures of my horse in the document?

A5 A digital camera is very useful for taking the required pictures. A little computer work can lead to a page containing the required pictures. This page can be printed with a colour printer. Alternatively, the colour pictures can be formatted or printed by many retail outlets which currently offer this service.

Q6 What are non permitted drugs?

A6 Non permitted drugs are drugs that have been determined should not be given or fed to equines which may be used for food. The list of non permitted drugs is available in section E.4 of this annex.

Q7 Is Phenylbutazone is banned?

A7 The use of Phenylbutazone in equines for medical reasons is not currently banned in Canada. However; Phenylbutazone is not permitted to be used in any animals that may be used for food including equine. (See Question and Answer 6.)

Q8 Do we have to keep a record of feed supplements or nutraceuticals?

A8 It would depend on the ingredients contained in the feed supplement or nutraceutical. Most feed supplements contain in addition to feed ingredients, vitamins and minerals which do not have withdrawal periods, so they would not need to be declared on the EID. Similarly, nutraceutical formulations of substances that naturally occur in the body do not have withdrawal periods. If, however, the supplement or nutraceutical did contain a drug ingredient, the supplement/nutraceutical would need to be declared on the EID. When in doubt, consult your veterinarian.

Q9 What is a withdrawal period?

A9 A withdrawal period is the minimum number of days or hours that must expire since the last treatment of a specified medication or vaccine (used as per label directions) before the animal may be slaughtered for food.

Q10 Where do I get the information for drug withdrawal periods?

A10 Section E.5 of this annex contains a list of drugs for which a 6 month withdrawal period is required. Section E.6 of this annex is to be available in April 2010, and will contain a list of drugs that are safe to be given or fed to equines which may be used for food. Withdrawal periods for these named drugs will be included with this list. With respect to drugs that can be safely given or fed to equines which may be used for food that may not appear on the list, consult your veterinarian for information regarding withdrawal periods.

Q11 What do I do about recording withdrawal periods for drugs my veterinarian tells me are safe for use in other food producing animals, but have no label instructions regarding the use in equines destined for food, or have a label statement that says not for use in equines intended to be slaughtered for food?

A11 For now, record the information required by the EID with respect to drug identification and use. Then contact your veterinarian and record withdrawal period information as provided by your veterinarian including the authority consulted by your veterinarian for establishing these withdrawal periods (e.g. gFARAD, veterinary college specialist etc.).

Q12 Are these new rules expected to change?

A12 Yes, these new requirements are only the first step towards strengthening Canada's food safety and traceability system for equines.

Q13 Will imported horses be subject to the same requirements?

A13 Yes, imported horses when presented for slaughter at Canadian slaughter establishments will be required to meet this new Canadian standard for equine meat production in Canada.

Q14 Will these requirements only apply to meat products exported to the European Union?

A14 No, these requirements will apply to all equines presented for slaughter in Canadian Food Inspection Agency (CFIA) inspected facilities.

Q15 Who will be responsible for checking the EIDs before slaughter?

A15 The primary responsibility for compliance to requirements in slaughter facilities inspected by the CFIA remains with the operator of the establishment. The establishment operator will be required to ensure each equine presented for slaughter has a complete and acceptable EID covering at least a six month consecutive time period before slaughter. The CFIA will oversee the effectiveness of the operator's ante mortem review procedures with respect to the EID.

Q16 Is it possible to include more than one horse on an EID?

A16 The EID represents the minimum information required prior to slaughter in an acceptable format. However, certain conditions may exist that would allow for multiple equine animals to be included on one EID type document such as holding a group of equines for a six month period with a recorded inventory control system. If common medical history, medication history and owner declaration can be made and recorded in an acceptable record format deemed satisfactory to the CFIA, a common EID may be acceptable. The CFIA must give prior approval to this record format and system prior to use. Contact the CFIA inspection services at the relevant CFIA inspected slaughter establishment for more details.

Q17 Are non permitted drugs not to be used in an equine presented for slaughter for the life of the animal or just for 6 months?

A17 The non permitted drugs are listed under Section E.4 of this annex. Non permitted drugs are not to be used in equines intended for food production. During a transition period, the EID will be reviewed to determine if equines have or have not been treated with non permitted drugs during the 6 months prior to their slaughter. A longer "certification period" will eventually be requested.

Q18 If I sell my equine at an auction, does the auction become the owner, that is have care and control of my equine, for a period of time and need to fill out an EID?

A18 No, the buyer of the animal assumes the care and control of the equine after the last date of care or control indicated by the previous owner's EID. The final date on the EID filled out by the previous owner will be the date the animal was delivered to the auction premise in this case. Any medication use on the auction premise is to be declared to the buyer by auction management. Generally this information is given to potential buyers from the auctioneer as the animal is sold.

Q19 I am forwarding a previous EID completed by a former owner to the buyer of my equine; am I responsible for the information on that previous EID?

A19 No. Each owner signs for the dates of care or control indicated on their own EID.

---

Previous page: Table of Contents